Form 4: Evolent Health Director Russell Monroe Glass Reports Acquisition of Restricted Stock Units

Director Russell Monroe Glass reports acquisition of 1,163 restricted stock units in Evolent Health, Inc.

Summary

• Russell Monroe Glass, a director of Evolent Health, Inc., filed a Form 4 disclosing changes in beneficial ownership.
• On March 1, 2024, Mr. Glass acquired 1,163 shares of Class A Common Stock in the form of restricted stock units.
• These restricted stock units were granted pursuant to the Evolent Health, Inc. 2015 Omnibus Incentive Compensation Plan.
• The shares vest on the earlier of March 1, 2025, and the date of the Company's 2024 annual meeting, contingent upon continued service.
• Mr. Glass also indirectly owns 6,046 shares of Class A Common Stock through a trust.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director suggests confidence in the company's prospects, but it's a routine transaction.

Positives

• The acquisition of restricted stock units by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The vesting of the restricted stock units is contingent upon the reporting person's continued service, aligning their interests with the company's long-term success.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing is typical for directors receiving equity compensation.

Stakeholder Impact

• The transaction has a minor positive impact on shareholders as it aligns the director's interests with the company's performance.

Next Steps

• Monitor future Form 4 filings to track changes in insider ownership.
• Observe the company's performance leading up to the vesting date of the restricted stock units.

Key Dates